$358.41–$407.43
Use 52287 for bladder chemodenervation injections. Use 52204 when the cystoscopy includes biopsy of bladder tissue.
On this page
CMS RVU26D · Effective 2026-10-01
52287 Bladder chemodenervation Medicare reimbursement rates in Maryland
Reports cystoscopic injection of a chemodenervation agent into the bladder for conditions such as overactive bladder or neurogenic detrusor overactivity. Compare 52287 office and facility rates across CMS payment localities in Maryland.
Amounts below use the non-QP conversion factor for participating physicians. These are base physician payments before claim-level adjustments, not patient costs or total hospital charges.
What does Medicare pay for 52287 in Maryland?
Maryland has 3 payment localities in this comparison. Use the service location to choose the applicable amount. These are the supported base rates for the 3 payment areas shown below, using the same CMS release.
Office / nonfacility
$366.54–$414.63
3 of 3 localities have a supported rate.
Facility setting
$149.20–$161.63
3 of 3 localities have a supported rate.
These are locality ranges, not averages or address-specific quotes. A facility-setting amount covers the physician service; it does not include a hospital’s separate bill. Choose a locality below to inspect its calculation, compare other payment areas, or price a percentage of Medicare.
Where 52287 pays more and less in Maryland
3 payment localities
$366.54 to $414.63
Urology procedure
About 52287: Bladder chemodenervation by cystoscopy
Reports cystoscopic injection of a chemodenervation agent into the bladder for conditions such as overactive bladder or neurogenic detrusor overactivity.
A urologist typically performs this procedure by passing a cystoscope through the urethra and injecting a chemodenervation agent into the bladder wall. Common indications include overactive bladder with inadequate response or intolerance to medication and neurogenic detrusor overactivity. The code represents the cystoscopic injection service, not a biopsy or treatment of a bladder lesion. When the practice supplies onabotulinumtoxinA, the drug may be reported separately using the applicable drug code.
Report the service for the cystoscopic chemodenervation session; document the indication, agent and dose, injection sites, and procedure performed. The procedure has a 0-day global period, so same-day preoperative and postoperative care is included. When related endoscopies are performed together, endoscopy-family pricing applies. Modifier 50 is inappropriate for this service. Medicare does not pay an assistant at surgery, and co-surgeon and team-surgery reporting are not permitted. The physician fee schedule has different practice-expense inputs for office and facility settings.
CMS billing rules for 52287
- Global period
- Minor procedure with a 0-day global period: same-day preoperative and postoperative care is included.
- Multiple procedures
- Endoscopy family pricing applies when related endoscopies are performed together.
- Bilateral procedures
- Bilateral adjustment does not apply; the descriptor or anatomy makes modifier 50 inappropriate.
- Assistant at surgery
- Statutory restriction: assistant at surgery is not paid.
- Co-surgeons
- Co-surgeons not permitted.
- Team surgery
- Team surgery not permitted.
Where the value comes from
- Work RVU3.12 · 29%
- Practice expense (office) RVU7.34 · 67%
- Malpractice RVU0.43 · 4%
84K
Medicare services in 2024 · #615 by national volume
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
52287 compared with similar codes
Office rates for Maryland, from the same CMS release.
$767.52–$878.10
52287 describes injection for bladder chemodenervation; 52224 is for cystoscopic treatment of a bladder lesion.
$734.62–$841.90
52287 involves injections into the bladder wall for chemodenervation. 52214 is used for cystoscopic fulguration or other treatment at specified urinary-tract sites.
Compare 52287 by payment locality
Find the payment area for your service address, then open its rate page for calculation inputs, release history and the percentage-of-Medicare tool. A city may cross payment-area boundaries; the ZIP lookup above helps resolve the location.
3 of 3 payment localities
Baltimore/Surr. Cntys →
Office / nonfacility
$386.70
Facility
$156.26
Dc + Md/Va Suburbs →
Office / nonfacility
$414.63
Facility
$161.63
Rest Of Maryland →
Office / nonfacility
$366.54
Facility
$149.20
Need rates for a whole code list?
Fee-sheet and API access are in early access. Tell us which codes and locations your team needs.
52287 billing questions
How is this different from cystoscopy with biopsy?
52287 reports injections intended to chemodenervate the bladder. A biopsy code is for sampling bladder tissue, not for the therapeutic injection.
Can the medication be reported separately?
When the practice supplies onabotulinumtoxinA, report the drug separately using the applicable drug code. The cystoscopic injection service is reported with 52287.
Should modifier 50 be appended?
No. The CMS bilateral adjustment does not apply, and modifier 50 is inappropriate for this service.
What happens when another related endoscopy is performed at the same session?
CMS endoscopy-family pricing applies when related endoscopies are performed together. Documentation should identify each distinct service performed.
What documentation supports 52287?
Document the bladder condition being treated, the chemodenervation agent and dose, the cystoscopic injection procedure, and the sites treated.
Can an assistant or co-surgeon be reported?
Medicare does not pay an assistant at surgery for this service. Co-surgeons and team surgery are not permitted.
Where these rates come from
FeeBase calculates base physician payments from CMS work, practice-expense, and malpractice RVUs, adjusted by each locality’s geographic indices and the applicable conversion factor. Unavailable or separately priced services are labeled rather than assigned a made-up amount.
Source: RVU26D. Effective 2026-10-01 through the day before 2027-01-01.
6,12652283,,Cystoscopy and treatment,A,,3.64,5.83,,1.24,,0.47,9.94,5.35,0,000,0.00,0.00,0.00,3,0,1,0,0,9,52000,33.4009,09,0,99,0.00,0.00,0.00
6,12752284,,Cysto rx balo cath urtl strx,A,,3.02,76.91,,0.96,,0.39,80.32,4.37,0,000,0.00,0.00,0.00,3,0,1,0,0,9,52000,33.4009,09,0,99,0.00,0.00,0.00
6,12852285,,Cystoscopy and treatment,A,,3.51,5.76,,1.19,,0.49,9.76,5.19,0,000,0.00,0.00,0.00,3,0,1,0,0,9,52000,33.4009,09,0,99,0.00,0.00,0.00
6,12952287,,Cystoscopy chemodenervation,A,,3.12,7.34,,0.91,,0.43,10.89,4.46,0,000,0.00,0.00,0.00,3,0,1,0,0,9,52000,33.4009,09,0,99,0.00,0.00,0.00
6,13052290,,Cystoscopy and treatment,A,,4.47,1.41,NA,1.41,,0.57,6.45,6.45,0,000,0.00,0.00,0.00,3,2,1,0,0,9,52000,33.4009,09,0,99,0.00,0.00,0.00
6,13152300,,Cystoscopy and treatment,A,,5.17,1.57,NA,1.57,,0.66,7.40,7.40,0,000,0.00,0.00,0.00,3,2,0,0,0,9,52000,33.4009,09,0,99,0.00,0.00,0.00
6,13252301,,Cystoscopy and treatment,A,,5.36,1.60,NA,1.60,,0.68,7.64,7.64,0,000,0.00,0.00,0.00,3,2,0,0,0,9,52000,33.4009,09,0,99,0.00,0.00,0.00